FlowTriever2 Pulmonary Embolectomy Clinical Study

NACompletedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

February 14, 2023

Primary Completion Date

September 9, 2024

Study Completion Date

September 9, 2024

Conditions
Pulmonary Embolism
Interventions
DEVICE

FlowTriever2 Catheter

The FlowTriever2 Catheter is utilized for the treatment of Pulmonary Embolism via mechanical thrombectomy of thrombus in the pulmonary arteries.

Trial Locations (7)

31404

Memorial Health University Medical Center, Savannah

37920

University of Tennessee Medical Center, Knoxville

40207

Baptist Health, Louisville

74104

Oklahoma Heart Institute, Tulsa

85711

Carondelet St. Joseph's Hospital, Tucson

06511

Yale University, New Haven

08103

Virtua Health, Camden

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Inari Medical

INDUSTRY

NCT05560763 - FlowTriever2 Pulmonary Embolectomy Clinical Study | Biotech Hunter | Biotech Hunter